Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease

Hyung Ho Yoon, Jin Hoon Park, Yong Hwan Kim, Joongkee Min, Eunmi Hwang, Changjoon Lee, Jun Kyo Francis Suh, Onyou Hwang, Sang Ryong Jeon

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

BACKGROUND: The inhibition of neuronal activity by electrical deep brain stimulation is one of the mechanisms explaining the therapeutic effects in patients with Parkinson disease (PD) but cannot specifically activate or inactivate different types of neurons. Recently, a new technology based on optogenetics has been developed to modulate the activity of specific neurons. However, the therapeutic effects of optical inactivation in the subthalamic nucleus (STN) have not been fully investigated. OBJECTIVE: To perform various behavioral tests to evaluate changes in motor functions in a PD rat model after optogene expression and, unlike previous studies, to assess the therapeutic effects of direct optogenetic inactivation in the STN. METHODS: 6-Hydroxydopamine-induced hemiparkinsonian rats received injections of hSynapsin1-NpHR-YFP adeno-associated virus or an equivalent volume of phosphatebuffered saline. Three weeks after injection of adeno-associated virus or phosphatebuffered saline, the optic fiber was implanted into the ipsilateral STN. A stepping test, a cylinder test, and an apomorphine-induced rotation test were performed in 3 sequential steps: during light-off state, during light stimulation, and again during light-off state. RESULTS: Stepping tests revealed that optical inhibition of the STN significantly improved 6-hydroxydopamine- induced forelimb akinesia. PD motor signs, as assessed by cylinder and apomorphine tests, were not affected by optical inhibition. Immunofluorescence revealed that halorhodopsin was highly expressed and colocalized with vesicular glutamate transporter 2 in the STN. CONCLUSION: Optogenetic inhibition in the STN may be effective in improving contralateral forelimb akinesia but not in changing forelimb preference or reducing dopaminergic receptor supersensitivity. These findings are useful as a basis for future studies on optogenetics in PD.

Original languageEnglish
Pages (from-to)533-540
Number of pages8
JournalNeurosurgery
Volume74
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Optogenetics
Subthalamic Nucleus
Forelimb
Parkinson Disease
Therapeutic Uses
Dependovirus
Apomorphine
Oxidopamine
Vesicular Glutamate Transport Protein 2
Halorhodopsins
Neurons
Injections
Deep Brain Stimulation
Fluorescent Antibody Technique
Technology
Light
Inhibition (Psychology)

Keywords

  • Deep brain stimulation
  • Forelimb akinesia
  • Halorhodopsin
  • hSynapsin1
  • Optogenetics
  • Parkinson disease
  • Subthalamic nucleus

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease. / Yoon, Hyung Ho; Park, Jin Hoon; Kim, Yong Hwan; Min, Joongkee; Hwang, Eunmi; Lee, Changjoon; Francis Suh, Jun Kyo; Hwang, Onyou; Jeon, Sang Ryong.

In: Neurosurgery, Vol. 74, No. 5, 01.01.2014, p. 533-540.

Research output: Contribution to journalArticle

Yoon, HH, Park, JH, Kim, YH, Min, J, Hwang, E, Lee, C, Francis Suh, JK, Hwang, O & Jeon, SR 2014, 'Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease', Neurosurgery, vol. 74, no. 5, pp. 533-540. https://doi.org/10.1227/NEU.0000000000000297
Yoon, Hyung Ho ; Park, Jin Hoon ; Kim, Yong Hwan ; Min, Joongkee ; Hwang, Eunmi ; Lee, Changjoon ; Francis Suh, Jun Kyo ; Hwang, Onyou ; Jeon, Sang Ryong. / Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease. In: Neurosurgery. 2014 ; Vol. 74, No. 5. pp. 533-540.
@article{014bcf6303a54755a6c99e9e67e0c517,
title = "Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease",
abstract = "BACKGROUND: The inhibition of neuronal activity by electrical deep brain stimulation is one of the mechanisms explaining the therapeutic effects in patients with Parkinson disease (PD) but cannot specifically activate or inactivate different types of neurons. Recently, a new technology based on optogenetics has been developed to modulate the activity of specific neurons. However, the therapeutic effects of optical inactivation in the subthalamic nucleus (STN) have not been fully investigated. OBJECTIVE: To perform various behavioral tests to evaluate changes in motor functions in a PD rat model after optogene expression and, unlike previous studies, to assess the therapeutic effects of direct optogenetic inactivation in the STN. METHODS: 6-Hydroxydopamine-induced hemiparkinsonian rats received injections of hSynapsin1-NpHR-YFP adeno-associated virus or an equivalent volume of phosphatebuffered saline. Three weeks after injection of adeno-associated virus or phosphatebuffered saline, the optic fiber was implanted into the ipsilateral STN. A stepping test, a cylinder test, and an apomorphine-induced rotation test were performed in 3 sequential steps: during light-off state, during light stimulation, and again during light-off state. RESULTS: Stepping tests revealed that optical inhibition of the STN significantly improved 6-hydroxydopamine- induced forelimb akinesia. PD motor signs, as assessed by cylinder and apomorphine tests, were not affected by optical inhibition. Immunofluorescence revealed that halorhodopsin was highly expressed and colocalized with vesicular glutamate transporter 2 in the STN. CONCLUSION: Optogenetic inhibition in the STN may be effective in improving contralateral forelimb akinesia but not in changing forelimb preference or reducing dopaminergic receptor supersensitivity. These findings are useful as a basis for future studies on optogenetics in PD.",
keywords = "Deep brain stimulation, Forelimb akinesia, Halorhodopsin, hSynapsin1, Optogenetics, Parkinson disease, Subthalamic nucleus",
author = "Yoon, {Hyung Ho} and Park, {Jin Hoon} and Kim, {Yong Hwan} and Joongkee Min and Eunmi Hwang and Changjoon Lee and {Francis Suh}, {Jun Kyo} and Onyou Hwang and Jeon, {Sang Ryong}",
year = "2014",
month = "1",
day = "1",
doi = "10.1227/NEU.0000000000000297",
language = "English",
volume = "74",
pages = "533--540",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of parkinson disease

AU - Yoon, Hyung Ho

AU - Park, Jin Hoon

AU - Kim, Yong Hwan

AU - Min, Joongkee

AU - Hwang, Eunmi

AU - Lee, Changjoon

AU - Francis Suh, Jun Kyo

AU - Hwang, Onyou

AU - Jeon, Sang Ryong

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND: The inhibition of neuronal activity by electrical deep brain stimulation is one of the mechanisms explaining the therapeutic effects in patients with Parkinson disease (PD) but cannot specifically activate or inactivate different types of neurons. Recently, a new technology based on optogenetics has been developed to modulate the activity of specific neurons. However, the therapeutic effects of optical inactivation in the subthalamic nucleus (STN) have not been fully investigated. OBJECTIVE: To perform various behavioral tests to evaluate changes in motor functions in a PD rat model after optogene expression and, unlike previous studies, to assess the therapeutic effects of direct optogenetic inactivation in the STN. METHODS: 6-Hydroxydopamine-induced hemiparkinsonian rats received injections of hSynapsin1-NpHR-YFP adeno-associated virus or an equivalent volume of phosphatebuffered saline. Three weeks after injection of adeno-associated virus or phosphatebuffered saline, the optic fiber was implanted into the ipsilateral STN. A stepping test, a cylinder test, and an apomorphine-induced rotation test were performed in 3 sequential steps: during light-off state, during light stimulation, and again during light-off state. RESULTS: Stepping tests revealed that optical inhibition of the STN significantly improved 6-hydroxydopamine- induced forelimb akinesia. PD motor signs, as assessed by cylinder and apomorphine tests, were not affected by optical inhibition. Immunofluorescence revealed that halorhodopsin was highly expressed and colocalized with vesicular glutamate transporter 2 in the STN. CONCLUSION: Optogenetic inhibition in the STN may be effective in improving contralateral forelimb akinesia but not in changing forelimb preference or reducing dopaminergic receptor supersensitivity. These findings are useful as a basis for future studies on optogenetics in PD.

AB - BACKGROUND: The inhibition of neuronal activity by electrical deep brain stimulation is one of the mechanisms explaining the therapeutic effects in patients with Parkinson disease (PD) but cannot specifically activate or inactivate different types of neurons. Recently, a new technology based on optogenetics has been developed to modulate the activity of specific neurons. However, the therapeutic effects of optical inactivation in the subthalamic nucleus (STN) have not been fully investigated. OBJECTIVE: To perform various behavioral tests to evaluate changes in motor functions in a PD rat model after optogene expression and, unlike previous studies, to assess the therapeutic effects of direct optogenetic inactivation in the STN. METHODS: 6-Hydroxydopamine-induced hemiparkinsonian rats received injections of hSynapsin1-NpHR-YFP adeno-associated virus or an equivalent volume of phosphatebuffered saline. Three weeks after injection of adeno-associated virus or phosphatebuffered saline, the optic fiber was implanted into the ipsilateral STN. A stepping test, a cylinder test, and an apomorphine-induced rotation test were performed in 3 sequential steps: during light-off state, during light stimulation, and again during light-off state. RESULTS: Stepping tests revealed that optical inhibition of the STN significantly improved 6-hydroxydopamine- induced forelimb akinesia. PD motor signs, as assessed by cylinder and apomorphine tests, were not affected by optical inhibition. Immunofluorescence revealed that halorhodopsin was highly expressed and colocalized with vesicular glutamate transporter 2 in the STN. CONCLUSION: Optogenetic inhibition in the STN may be effective in improving contralateral forelimb akinesia but not in changing forelimb preference or reducing dopaminergic receptor supersensitivity. These findings are useful as a basis for future studies on optogenetics in PD.

KW - Deep brain stimulation

KW - Forelimb akinesia

KW - Halorhodopsin

KW - hSynapsin1

KW - Optogenetics

KW - Parkinson disease

KW - Subthalamic nucleus

UR - http://www.scopus.com/inward/record.url?scp=84899642198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899642198&partnerID=8YFLogxK

U2 - 10.1227/NEU.0000000000000297

DO - 10.1227/NEU.0000000000000297

M3 - Article

C2 - 24463495

AN - SCOPUS:84899642198

VL - 74

SP - 533

EP - 540

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 5

ER -